EKNL – Confirmed bullish trend making for HUGE breakout

New Post Public Reply Private Reply Replies (0) Message Board
Arbel

EKNL – Confirmed bullish trend making for HUGE breakout Week

We hope everyone had a fantastic Thanksgiving holiday weekend and well rested, this week will definitely be loaded with excitement especially the way EKNL closed out the week confirming a bullish breakout trend.

EKNL closed Friday’s session up 10.37% to $0.415 and clearly the Bullish Harmani Cross pattern confirmed EKNL is in solid bullish mode this week. With key monster updates expected from the company, investors are in for an XTREME week of XTREME gains.

http://www.xtremepicks.com/wp-content/uploads/2012/11/DROPEKNL2.gif Interesting enough EKNL is showing the same pattern and timing from our monster 2011 winner DROP (+83,000% gains) and is matching the exact same set up and pattern just prior to its HUGE bullish run.

After DROP ‘s initial breakout run to $0.75, prices consolidated at support levels and DROP triggered a Bullish Harmani Cross Pattern near the end of Nov 2011 and never looked back soaring from $0.30s to our target price of $1.25 in December.

EKNL just triggered a Bullish Harmani Cross Pattern last week and confirmed with Friday’s session. With our $2 near term price target we are on the right track to hit this level and if history repeats just as we have seen with DROP, December will be a KEY breakout month for monster Gains – Making this week a prime week to add and accumulate for MEGA gains.

We are super excited of what’s to come this week and technicals confirmed a solid bullish reversal.

“Bullish Harami Cross Pattern”

http://www.candlesticker.com/images/31FIG.gif The Bullish Harami Cross Pattern is a major bullish reversal pattern and more significant than a regular Bullish Harami Pattern.

Bullish Harami Cross Pattern is a major upside reversal pattern. Short traders will not be wise to ignore the significance of a Harami cross just after a long black candlestick. Harami crosses point out to the bottoms.

The best part of this is that EKNL’s active float of 5.5 million shares will definitely make prices soar much faster and much higher than DROP

EKNL potential is is too good to pass up especially at these levels and we are committing to profile EKNL for the whole month and well into December bringing you the MONSTER updates and HUGE gains!

EKO International Corp.

Of course what really stands EKNL apart from everyone else is the relationships and key connections it has build so far.

imd Teaming up with iMDhealth.ca network just gave EKNL access to thousands of physician , diabetes education centers and health care providers for diabetics across Canada - practically becoming EKNL’s sales force for the treatment of Nueropathy and the FREMS FDA approved technology.

EKNL released monster news announcing EKO’s Dr. Ziemer of NeuroVasc Medical Inc. and NCI, distributor of Neurometrix (NASDAQ:NURO)’s NC-Stat DPN check device are now available in 100 of WalMart-Canada stores.” Dr. Paul Ziemer, world renowned for his expertise in the medical field joined the team at EKNL.

http://www.themayerinstitute.ca/wp-content/themes/starkers-for-storyboard/images/logo.png EKNL launched first of many Clinics including recent announcement of launching clinics in the USA. These clinics will start to treat patients with their FDA approved FREMS technology that was also presented at the 13th annual Medical last month!

Also, Dr. Ziemer teamed up with Dr. Snow of Neurometrix, a NASDAQ Listed company (NURO) for exclusive hands on demonstration of their testing unit at the show.

No doubt, these are MONSTER updates that are turning a lot of heads, and institutional investors now eying that multi-dollar target level.

These updates already give EKNL HUGE valuation and potential…

…BUT, IT IS WHAT’S STILL TO BE UNLEASHED BY EKNL THAT WILL NOT ONLY BE MIND ‘BLOWING’ IT WILL PROPEL EKNL PRICES ’SKY HIGH’ AND INTO RECORD TERRITORY

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 0

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Altitude+ and ViewLift Celebrate Record Fan Engagement

Updated Category News Views 38

Fresh Off the Bench: Altitude+ Rises Picture this: you're cruising through October, watching the leaves fall and the puck drop, and here come Altitude+ and ViewLift boasting some record numbers. This ain't your everyday puff piece — they've got concrete results to back it up. Altitude+, charging into the 2026–27 NHL and NBA seasons, isn't just surviving; they're...

Continue Reading
HPV Vaccine Innovations and Global Collaboration at IPVS 2026

Updated Category News Views 24

Listening and Learning on the Global Stage Stepping into IPVS 2026 felt like entering a melting pot of shared goals and renewed hope against HPV and cervical cancer. IX, strutting in with its sleeves rolled up, embodied the spirit of 'Together Against HPV' and didn’t shy away from showing its commitment to the cause. It wasn’t just about making noise; it was about...

Continue Reading
Icahn Enterprises Set for Q3 Earnings Review

Updated Category News Views 38

Icahn Enterprises Prepares for Third Quarter Insights There's something about quarterly earnings calls that gets the adrenaline pumping for investors, especially when it's about a giant like Icahn Enterprises L.P. We're talking a behemoth that wrestles in everything from energy to food packaging. If you're not eyeing this already, you probably should be. On November 3,...

Continue Reading
AvePoint Joins S&P SmallCap 600, Replacing LXP

Updated Category News Views 0

Shifting Scenes in the SmallCap Index Wall Street always throws a curveball right when you think you've seen it all. This time, it's AvePoint Inc. (NASD: AVPT) making waves as it steps into the S&P SmallCap 600 ring come November 2. Booting out LXP Industrial Trust (NYSE: LXP), this whole shuffle's coming down because those guys over at Brookfield Asset Management Ltd....

Continue Reading
Advanced Process Solutions Reshuffles Leadership Amid Growth

Updated Category News Views 131

Clint Johnson Ascends as VP Amidst Strategic Moves Clint Johnson's climb to Vice President of Services and Operations at Advanced Process Solutions (APS) ain't just routine corporate ladder gymnastics—it's a sign of shifting tides. Slapping your buddy’s back after years in the trenches, that kind of camaraderie translates into momentum. The precision manufacturing...

Continue Reading
San Simeon Estate Unveils New Paso Robles Tasting Room

Updated Category News Views 48

A New Chapter in Paso Robles Alright, it looks like the Riboli family is rolling out the red carpet at their fresh digs in Paso Robles, and it's more than just your average tasting room fluff. Nestled in the Willow Creek District, this isn't some ramshackle outpost—they're mixing wine tradition with a dollop of Central Coast flair. For investors eyeing lifestyle and...

Continue Reading
Evaluating PT and OT Benefits: What’s Driving Outcomes?

Updated Category News Views 86

Shifting Gears: Rethinking PT and OT Benefits With an uptick in conversations around physical therapy (PT) and occupational therapy (OT) benefits, it's time for health plans and employers to step up their game. Let's face it: we're not just treating aches and pains anymore. We're dealing with the big picture here - helping folks get back to their daily grind effectively...

Continue Reading
San Diego's Iconic Nightlife Venue Revives as The Quin

Updated Category News Views 66

The ghosts of PLUXX's past are getting a new home at The Quin in San Diego. It's happening in the Gaslamp Quarter, where the familiar pulse of a party will hit the scene once again. Instead of peeling walls and the typical downtown club smell, we've got internationally acclaimed DJ Sam Feldt headlining the Halloween bash—Heaven & Hell. The Quin's Next Chapter Begins on...

Continue Reading
AI Innovation Incubator Shakes Up Shanghai's Lingang

Updated Category News Views 121

Incubator Conference Lights Up Lingang Hold onto your hats, folks! Shanghai's Lingang Center is buzzing with activity as the 'World Top-performing Incubator Conference 2026' kicks off. Taking place from October 26 to 28, this gathering isn't just another run-of-the-mill tech meet-up. Oh no, it's about redefining how we talk about innovation, incubation, and the future,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Market Sentiment for Himax Technologies Inc. Stock

Updated Category News Views 96

Understanding Himax Technologies Inc's Stock Sentiment Himax Technologies Inc (NYSE:HIMX) has shown an interesting trend in its short interest recently. The percentage of shares sold short has increased by 8.02% since the last report. As of now, approximately 3.74 million shares are sold short, which accounts for about 2.83% of the total shares available for trading....

Continue Reading
Ant International Elevates Digital Payments with AI Innovations

Updated Category News Views 134

Ant International Enhances Digital Payment Solutions Ant International, a key player in the global digital payment and financial technology sphere, has outlined a transformative journey through 2024 with significant advancements across its four primary sectors: Alipay+, Antom, WorldFirst, and Embedded Finance. The company is capitalizing on growth opportunities and...

Continue Reading
BC Platforms Unveils Game-Changing AI Technology for Researchers

Updated Category News Views 256

BC Platforms Introduces BC Catalyst for Precision Medicine BC Platforms has officially launched BC Catalyst, an innovative AI-native analytics product designed to enhance precision medicine. This breakthrough technology integrates genomic and real-world data, allowing for actionable insights throughout the entire drug lifecycle. With BC Catalyst, the company aims to...

Continue Reading
Innovative AI Solutions from Standard Metrics for Investors

Updated Category News Views 130

Standard Metrics Unveils Game-Changing AI Analyst Tool Standard Metrics recently launched an exciting feature aimed at enhancing portfolio analysis for venture capital and private equity firms. This new tool, known as the AI Analyst, revolutionizes how investors interact with their portfolio data. Empowering Investors with Instant Insights The AI Analyst facilitates a...

Continue Reading
Archer Aviation Inc: Understanding Market Sentiment Shifts

Updated Category News Views 161

Understanding Archer Aviation Inc’s Short Interest Rise Archer Aviation Inc (NYSE: ACHR) has recently seen a notable increase in its short interest as a percentage of the float, rising by 9.33% since its last report. This surge translates to approximately 101.41 million shares sold short, reflecting 18.64% of the total shares available for trading. Based on current...

Continue Reading